Member Info for Rickylfc5

Stt1 - so you can predict a lower cash balance and a 10p share price but you question whether I can predict a cash balance

More speculation from Sol - the list continues

- can’t see any new trials being signed up due to RFK (less than 24hours before one announced)

- discounted a £20m deal back to £11.5m

- redundancies ahead

More nonsense to come

Sol - they will be invoicing £26m in H2 (and making £6m EBITDA) - the invoices will be paid and that means cash rolling in - quite simple really ( the only unknown is Capex to fit out the new lab and any development capital)

Stt1 - Of course I haven’t seen the figures but that’s my estimation (£40m) based upon £37m at the half year plus 6 months of £6 or £7m EBITDA and a large Debtor in the accounts at the end of H1 (that would have been paid in H2) You obviously don’t agree - show me your calculations

10p your having a laugh (they’ve got 6p of cash) and fat profits and no borrowings - this isn’t Totally (where you failed to see a decline coming from 30p to below 10p

Stt1 - so if the CEO wants to make big bucks on his options he will talk up the 2025 outlook - is that what you are saying???

Solvista - your thoughts on no contracts didn’t age well - now where’s our friend stt1????

He can stay

Stt1 - can we do a deal as most posters are fed up of your endless repetitive warnings against Hvivo (you were warning when the share price was 9p and it went to 30p)

If the share price hits 28p before the end of Jan you will hold up your hands, admit misjudgement, and leave this board for good??

The share price would have gone down a lot more than 0.1p if those millions traded had been sells

Stt1 - great time for you to load up. You missed the last rise from 9p to 30p (you stayed in Totally which went from 30p to 6p) don’t miss this one again !!

Stt - you have never acknowledged you were wrong with your assertion that cash will be lower at the end of H1 - have some self respect and hold your hands up. You also need to look at yourself when you warned HVO shareholders of the dangers of our investment (when the shares were 10p) compared to Totally which at the time were 28p - are you surprised that people view your opinions as laughable considering that share prices are almost exactly the opposite way around and how much better off you would have been if you had ignored tour own advice

Marc - the reason it is worth £60m is that all of its programs have progressed over the last few years. More specifically Polb001 has proved to be safe and effective in reducing the negative side effects of Cancer Immunotherapy treatments- - a further trial is about to commence to gather more data. The potential market for Polb001 (if the trial proves successful) is massive hence the high ish valuations. The current share price could prove to be negligible if and when they have more trial info - Buy for high risk reward - Don’t Buy if you are looking for safe / steady returns

Stt - why won’t you discuss your failed assertion of a cash decline???

The CRO market is over $30billion annually - why do any of the CRO Companies continue if (as you assert) they can just be replaced by more competitive Companies in China or India?? HVO are tiny within the CRO market. Obviously the western CRO providers have a skill set that is not easy to replicate in a way that would satisfy regulators and HVO have a particular sophisticated skill set hence we have a solid business model

Hard to see this one surviving - cash must be very low now and there are very little barriers for competitors to enter the market (no high tech know how or regulatory hoops) - questionable business model

Stt - have you held your hands up and admitted you were wrong in predicting that cash at the end of H1 would be lower than at the end of 23 - it would improve your credibility??

Maybe CF has seen the light and has cashed in his shares to invest in Totally as, after all, a shrinking, loss making POS that is shortly going to run out of cash is a much better investment

Mdle - your argument only works if he buys more Poolbeg - I suspect he sees Hvivo as ticking along with steady growth but feels he can get faster / greater returns elsewhere - a interview with him may help (or maybe not)

CF out - let’s hope Stt doesn’t notice

Stt - time for you to give up - you’ve been saying this is a risky share since the days when it was 10p (and probably during the earlier hype years) since then the Company has grown sales and profits , produced lots of cash, attracted institutional investors and the share price has trebled - you missed it and stuck with Totally which went exactly the opposite way - why don’t you show some humility and admit it when you’re wrong??